星光文化(01159.HK)至今已孵化開發共53個IP
星光文化(01159.HK)公布,公司至今在好萊塢簽約十個導演,已經孵化開發共53個IP。其中原創概念25個,改編28個。今年計劃進入製作6部,未來三年之內可進入製作47部,有衍生系列潛力的26部。
集團指。溫子仁執導的《致命感應》後期製作基本完成;山姆雷米製作、IrisK.Shim執導、金球獎影后吳珊卓主演的電影《阿媽》已經完成前製工作,準備在加拿大進入拍攝製作。
集團表示,鑒於新冠病毒疫情的形勢變化,會時刻關注疫情的影響,適當調整公司的業務發展計劃。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.